Work

The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance

Year: 2005

Type: article

Source: The FASEB Journal

DOI: 10.1096/fj.04-3177fje

Authors: Omar Jbilo, Christine Ravinet‐Trillou, Michèle Arnone, Isabelle Buisson, Estelle Bribes, Annick Péleraux, Géraldine Pénarier, Philippe Soubrié, Gérard Le Fur, Sylvaine Galiègue, Pierre Casellas

Institution: Sanofi (France)

Language: English

Topic: Adipose Tissue and Metabolism

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2154979992

FWCI: 26.52

Cites: 31

Cited by: 356

Related to: 10